Loading company…
Shenzhen-based Semacare makes cardiac monitoring products, including MetaCor, for early detection of cardiovascular disease.
Established in 2019 and based in Shenzhen, China, Semacare is a medical technology company focused on early detection of cardiovascular disease through monitoring and recovery systems. Its products include MetaCor, which collects cardiac data using the MetaAI machine learning algorithm, along with Homer and ZhixinPie. They are used in clinical and remote ECG diagnosis and monitoring. In July 2020 the company closed a Series A round, and as of 2024 it holds ISO9001 certification.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in